[ger] Die Eindâmmung der Arzneimitteikosten in Deutschiand, Frankreich und im Vereinigten Kônigreich . Deutschiand, Frankreich und das Vereinigte Kônigreich haben im Laufe der letzten zehn Jahre verschiedene MaBnahmen erprobt, die auf eine Eindâmmung des . Anstiegs der von der Allgemeinheit...

In 2008, the OECD launched a survey to collect information on the health systems characteristics of member countries. This paper presents the informaton provided by 29 of these countries in 2009. It describes country-specific arrangements to organise the population coverage against health risks...

This study assesses the potential of the concept of “mortality amenable to health care” as an indicator of outcome for health care systems. It presents estimates of the mortality amenable to health care in 31 OECD countries for the period 1997-2007. It measures the sensitivity of this...

[eng] Pharmaceutical industry regulation . Pharmaceutical industry regulation pursues three goals : respond to public health concerns, limit collective drug expenditures, and ensure competitiveness of national industry. The first goal issues are dealing with the assessment of the benefits/risks...

In recent years, the call for transparency in pharmaceutical pricing has gained momentum among policymakers and stakeholders. Following a resolution of the 72nd World Health Assembly and the establishment of the Oslo Medicines Initiative, there has been a concerted push for greater transparency...